Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)

Addiction

Volumn 99, Issue 4, 2004, Pages 450-460

  Digiusto, E ^a,c   Shakeshaft, A ^a   Ritter, A ^b   O'Brien, S ^a   Mattick, R P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b TURNING POINT ALCOHOL AND DRUG CENTRE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Adverse events; Buprenorphine; Heroin overdose; LAAM; Methadone; Naltrexone; NEPOD; Opioid dependence

Indexed keywords

BUPRENORPHINE; LEVACETYLMETHADOL; METHADONE; NALTREXONE;

APPENDECTOMY; ARTICLE; BRAIN HEMORRHAGE; CAUSE OF DEATH; CLINICAL TRIAL; COGNITIVE DEFECT; COLLAPSE; COMMUNITY CARE; DEHYDRATION; DRUG DETOXIFICATION; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; DRUG SCREENING; ECTOPIC PREGNANCY; ENCEPHALITIS; HEPATITIS; HOSPITAL CARE; HUMAN; HYPOGLYCEMIA; MEDICAL RECORD; OPIATE ADDICTION; PEPTIC ULCER; PNEUMONIA; SEIZURE; SPLENOMEGALY; SPONTANEOUS ABORTION; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; SYNCOPE; THORAX PAIN; TREATMENT WITHDRAWAL; VOMITING; WITHDRAWAL SYNDROME;

ADULT; ANALGESICS, OPIOID; AUSTRALIA; BUPRENORPHINE; FEMALE; HUMANS; MALE; METHADONE; METHADYL ACETATE; NALTREXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; OVERDOSE;

EID: 1942438170     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2004.00654.x     Document Type: Article

References (47)

1. Auriacombe, M., Frangues, P. & Tignol, J. (2001) Deaths attributable to methadone vs buprenorphine in France. Journal of the American Medical Association, 285, 45-46.
2. Bell, J. R., Young, M. R., Masterman, S. C., Morris, A., Mattick, R. P. & Bammer, G. (1999) A pilot study of naltrexone-accelerated detoxification in opioid dependence. Medical Journal of Australia, 171, 26-30.
3. Bennett, G. A. & Higgins, D. S. (1999) Accidental overdose among injecting drug users in Dorset, UK. Addiction, 94, 1179-1190.
4. Bird, S. M. & Hutchinson, S. J. (2003) Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99. Addiction, 98, 185-190.
5. Buster, M. C. A., van Brussel, G. H. A. & van den Brink, W. (2002) An increase in overdose mortality during the first two weeks after entering or re-entering methadone treatment in Amsterdam. Addiction, 97, 993-1001.
6. Caplehorn, J. R. M. (1998) Deaths in the first two weeks of maintenance treatment in NSW in 1994: identifying cases of iatrogenic methadone toxicity. Drug and Alcohol Review, 17, 9-17.
7. Caplehorn, J. R. M., Dalton, M. S. Y. N., Haldar, F., Petrenas, A.-M. & Nisbet, J. G. (1996) Methadone maintenance and addicts' risk of fatal heroin overdose. Substance Use and Misuse, 31, 177-196.
8. Chadderton, A. (2000) Clinical issues in using buprenorphine in the treatment of opiate dependence. Drug and Alcohol Review, 19, 329-335.
9. Clark, N., Lintzeris, N., Gijsbers, A., Whelan, G., Dunlop, A., Ritter, A. & Ling, W. (2003) LAAM maintenance vs methadone maintenance for heroin dependence. In: The Cochrane Library, Issue 3. Oxford: Update Software.
10. Daly, L. E. & Bourke, G. J. (2000) Interpretation and Uses of Medical Statistics, 5th edn. Oxford: Blackwell Science Ltd.
11. Darke, S., Ross, J., Zador, D. & Sunjic, S. (2000) Heroin-related deaths in New South Wales, Australia, 1992-96. Drug and Alcohol Dependence, 60, 141-150.
12. Deamer, R. L., Wilson, D. R., Clark, D. S. & Prichard, J. G. (2001) Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM). Journal of Addictive Diseases, 20, 7-14.
13. Digiusto, E., Mattick, R. P., Kimber, J., O'Brien, S., Doran, C., Henderson, N. & Breen, C. (2001) National evaluation of pharmacotherapies for opioid dependence - why have we done it? Drug and Alcohol Review, 20, 139-141.
14. Farre, M., Mas, A., Torrens, M., Moreno, V. & Cami, J. (2002) Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Drug and Alcohol Dependence, 65, 283-290.
15. Foy, A., Sadler, C. & Taylor, A. (1998) An open trial of naltrexone for opiate dependence. Drug and Alcohol Review, 17, 167-174.
16. Glasgow, N. J., Taylor, J., Bell, J. R., Young, M. R. & Bammer, G. (2001) Accelerated withdrawal from methadone maintenance therapy using naltrexone and minimal sedation: a case series analysis. Drug and Alcohol Review, 20, 213-221.
17. Golovko, A. I., Golovko, S. I., Leont'eva, L. V., Romanenko, O. I. & Konoplin, D. A. (2003) Molecular aspects of pharmacological activity of naltrexone and naloxone. Eksperimentalnaia I Klinicheskaia Farmakologiia, 66, 71-80.
18. Gossop, M., Stewart, D., Treacy, S. & Marsden, J. (2000) A prospective study of mortality among drug misusers a 4-year period after seeking treatment. Addiction, 97, 39-47.
19. Hayashi, K. & Walker, A. M. (1996) Japanese and American reports of randomized trials: differences in the reporting of adverse effects. Controlled Clinical Trials, 17, 99-110.
20. Ioannidis, J. P. A. & Lau, J. (2001) Completeness of safety reporting In randomised trials. An evaluation of 7 medical areas. Journal of the American Medical Association, 285, 437-443.
21. Jones, R., Gruer, L., Gilchrist, G., Seymour, A., Black, M. & Oliver, J. (2002) Recent contact with health and social services by drug misusers in Glasgow who died of a fatal overdose in 1999. Addiction, 97, 1517-1522.
22. Lee, S. C. & Yoburn, B. C. (2000) The effect of nimodipine on opioid antagonist-induced upregulatlon and supersensitivity. Pharmacology, Biochemistry and Behaviour, 66, 347-351.
23. Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S., Kintaudi, P., Wesson, D. R., McNicholas, L., Tusel, D. J., Malkerneker, U., Renner, J. A., Santos, E., Casadonte, P., Fye, C., Stine, S., Wang, R. I. H. & Segal, D. (1998) Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomised clinical trial. Addiction, 93, 475-486.
24. Ling, W., Klett, C. J. & Gillis, R. D. (1978) A cooperative clinical study of methadyl acetate. 1. Three-times-a-week regimen. Archives of General Psychiatry, 35, 345-353.
25. Ling, W., Wesson, D. R., Charuvastra, C. & Klett, J. (1996) A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of General Psychiatry, 53, 401-407.
26. Lintzeris, N., Bell, J., Bammer, G., Jolley, D. J. & Rushworth, L. (2002) A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal. Addiction, 97, 1395-1404.
27. Mattick, R. P., Ali, R., White, J. M., O'Brien, S., Wolk, S. & Danz, C. (2003) Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction, 98, 441-452.
28. McGregor, C., Ali, R., White, J. M., Thomas, P. & Gowing, L. (2002) A comparison of antagonist-precipitated withdrawal under anesthesia to standard in-patient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months. Drug and Alcohol Dependence, 68, 5-14.
29. McGregor, C., Darke, S., Ali, R. & Christie, P. (1998) Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction, 93, 701-711.
30. Miotto, K., McCann, M. J., Rawson, R. A., Frosch, D. & Ling, W. (1997) Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts. Drug and Alcohol Dependence, 45, 131-134.
31. Navaratnam, V., Jamaludin, A., Raman, N., Mohamed, M. & Mansor, S. M. (1994) Determination of naltrexone dosage for narcotic agonist blockade in detoxified Asian addicts. Drug and Alcohol Dependence, 34, 231-236.
32. Pani, P. P., Maremmani, I., Pirastu, R., Tagliamonte, A. & Gessa, G. L. (2000) Buprenorphine: a controlled trial in the treatment of opioid dependence. Drug and Alcohol Dependence, 60, 39-50.
33. Reynaud, M., Petit, G., Potard, D. & Courty, P. (1998) Six deaths linked to concomitant use of buprenorphine and benzodiazepines. Addiction, 93, 1385-1392.
34. Risser, D., Honlgschnabl, S., Stichenwirth, M., Pfudl, S., Sebald, D., Kaff, A. et al. (2001) Mortality of opiate users in Vienna, Austria. Drug and Alcohol Dependence, 64, 251-256.
35. Ritter, A. J. (2002) Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose. Australian and New Zealand Journal of Psychiatry, 36, 224-228.
36. Savage, C., Karp, E. G., Curron, S. F., Hanlon, T. E. & McCabe, O. L. (1976) Methadone/LAAM maintenance: a comparison study. Comprehensive Psychiatry, 17, 415-424.
37. Schuh, K. J., Walsh, S. L. & Stitzer, M. L. (1999) Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans. Psychopharmacology, 145, 162-174.
38. Seaman, S. R., Brettle, R. P. & Gore, S. M. (1998) Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ, 316, 426-428.
39. Senay, E. C., Dorus, W. & Renault, P. F. (1977) Methadyl acetate and methadone. An open comparison. Journal of the American Medical Association, 237, 138-142.
40. Tennant, F. S., Rawson, R. A., Pumphrey, E. & Seecof, R. (1986) Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM). Journal of Substance Abuse Treatment, 3, 195-202.
41. Therapeutic Goods Administration (2000) Note for guidance on clinical safety data management: definitions and standards for expedited reporting. CMPH/ICH/377/95. Commonwealth Department of Health and Aged Care. Canberra: TGA Publications Office.
42. Tucker, T. K. & Ritter, A. J. (2000) Naltrexone in the treatment of heroin dependence: a literature review. Drug and Alcohol Review, 19, 73-82.
43. Vormfelde, S. V. & Poser, W. (2001) Death attributed to methadone. Pharmacopsychiatry, 34, 217-222.
44. Warner-Smith, M., Darke, S. & Day, C. (2002) Morbidity associated with non-fatal heroin overdose. Addiction, 97, 963-967.
45. White, J. M. & Irvine, R. J. (1999) Mechanisms of fatal opioid overdose. Addiction, 94, 961-972.
46. Zador, D. & Sunjic, S. (2000) Deaths in methadone maintenance treatment in New South Wales, Australia 1990-95. Addiction, 95, 77-84.
47. Zanis, D. A. & Woody, G. E. (1998) One-year mortality rates following methadone treatment discharge. Drug and Alcohol Dependence, 52, 257-260.